| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/28/1994 | CA2146855A1 Recombinant humanized anti-cytomegalovirus antibodies |
| 04/28/1994 | CA2146854A1 Recombinant specific binding protein |
| 04/28/1994 | CA2144738A1 A subpopulation of mac-1 (cd11b/cd18) molecules which mediate neutrophil adhesion to icam-1 and fibrinogen |
| 04/28/1994 | CA2109159A1 Combination pediatric vaccine with enhanced immunogenicity of each vaccine component |
| 04/27/1994 | EP0594284A2 Antibody containing pharmaceutical composition against aids |
| 04/27/1994 | EP0593868A1 PEG-interferon conjugates |
| 04/27/1994 | EP0593857A1 Biologically active porcine somatotropin polypeptides and methods of using the same |
| 04/27/1994 | EP0593754A1 Peptides of human papilloma virus for use in human t cell response inducing compositions |
| 04/27/1994 | EP0593658A1 Compositions and methods for inhibiting leukocyte adhesion to cns myelin |
| 04/27/1994 | EP0593585A1 Peptide which abrogates tnf and/or lps toxicity |
| 04/27/1994 | EP0593471A1 Method for detecting immune dysfunction in asymptomatic aids patients and for predicting organ transplant rejection |
| 04/27/1994 | EP0485471B1 Natural human anti-gamma interferon antibodies detected and purified by synthetic peptides |
| 04/27/1994 | EP0408546B1 Improvements relating to drug delivery systems |
| 04/27/1994 | CN1085953A Human interleukin-13 |
| 04/27/1994 | CN1085910A Bio-guide medicine for anti-stomach cancer immunoglobulin-Y-phytotoxin-A |
| 04/27/1994 | CN1085805A Vaccine compositions |
| 04/26/1994 | US5306635 DNA encoding immunogenic gpIII glycoprotein of varicella-zoster virus |
| 04/26/1994 | US5306614 Methods and kits for diagnosing human immunodeficiency virus type 2(HIV-2) |
| 04/26/1994 | US5306508 Red blood cell surrogate |
| 04/26/1994 | US5306493 FeLV-infected feline cell line |
| 04/26/1994 | US5306492 Oligosaccharide conjugated to carrier protein |
| 04/26/1994 | CA1328808C Active agent and pharmaceutical composition containing such, for preventing and controlling human transplant rejection |
| 04/24/1994 | CA2109147A1 Kidney peptides |
| 04/21/1994 | CA2088222A1 Development of research, diagnostic and production tools for pro-hormone convertases |
| 04/20/1994 | EP0593339A1 Process preparation of hepatitis A antigen and vaccine |
| 04/20/1994 | EP0593291A2 Nonstructural protein of hepatitis C virus, and diagnostic method and kit using the same |
| 04/20/1994 | EP0593290A2 Core antigen protein of hepatitis C virus, and diagnostic method and kit using the same |
| 04/20/1994 | EP0592636A1 Process for the production of a viable cell culture infected by a multiple sclerosis associated virus |
| 04/20/1994 | EP0592582A1 Monoclonal antibody to lymphocyte-associated cell surface protein |
| 04/20/1994 | EP0592546A1 Immunodeficiency virus recombinant poxvirus vaccine |
| 04/20/1994 | EP0592521A1 Monoclonal antibodies specific for marrow-derived mesenchymal cells |
| 04/20/1994 | EP0592480A1 Papillomavirus l2 protein |
| 04/20/1994 | EP0592470A1 Pseudomonas exoenzyme s peptide composition and methods for their production |
| 04/20/1994 | CN1085450A Vaccines |
| 04/20/1994 | CN1085449A Improvements in or relating to vaccines |
| 04/20/1994 | CN1024285C Monoclonal antibody specific to neutrophils |
| 04/19/1994 | US5304636 Receptor for the human rhinovirus minor group |
| 04/19/1994 | US5304541 Methods using novel chimeric transforming growth factor-β1/β2 |
| 04/19/1994 | US5304472 Method of controlling polypeptide production in bacterial cells |
| 04/19/1994 | US5304466 HIV-3 retrovirus and its use |
| 04/19/1994 | US5304464 Protein complex enhancing sperm motility |
| 04/19/1994 | US5304371 Peptide for diagnosing and immunizing against T. cruzi infection |
| 04/19/1994 | US5304113 Method of eradicating infectious biological contaminants |
| 04/19/1994 | CA1328601C Preparation of t-cell and t-cell membrane for use in autoimmune diseases |
| 04/14/1994 | WO1994008026A1 Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system, particularly in brain |
| 04/14/1994 | WO1994008021A1 Immunogenic meningococcal lps and outer membrane vesicles and vaccine therefrom |
| 04/14/1994 | WO1994008013A1 Pilin variants and uses thereof |
| 04/14/1994 | WO1994008011A1 Recombinant mutant pasteurella multocida protein and process for preparing the same |
| 04/14/1994 | WO1994008008A1 Improvements in or relating to immune response modification |
| 04/14/1994 | WO1994008007A1 Trophic factor having ion channel-inducing activity in neuronal cells |
| 04/14/1994 | WO1994008000A1 Pseudorabies virus vaccine |
| 04/14/1994 | WO1994007995A1 Attenuated strains of aeromonas salmonicida useful as fish vaccines |
| 04/14/1994 | WO1994007922A1 Human neutralizing monoclonal antibodies to human immunodeficiency virus |
| 04/14/1994 | WO1994007921A1 Target binding polypeptide |
| 04/14/1994 | WO1994007920A1 Dna encoding a prostaglandin receptor, a host cell transformed therewith and an expression product thereof |
| 04/14/1994 | WO1994007534A1 High potency vaccines |
| 04/14/1994 | WO1994007533A1 Sequences of the hemagglutinins of recent strains of influenza type b virus |
| 04/14/1994 | WO1994007532A1 Method and composition for preserving antigens and process for utilizing cytological material produced by same |
| 04/14/1994 | WO1994007531A1 Method of enhancing cell mediated immune responses |
| 04/14/1994 | WO1994007530A1 Vaccines and antigenic conjugates |
| 04/14/1994 | WO1994007520A1 Method of treating rheumatoid arthritis with type ii collagen |
| 04/14/1994 | WO1994007517A1 Anti-inflammatory tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides |
| 04/14/1994 | WO1994007516A1 Anti-inflammatory, tolerogenic and immunostimulatory properties of carbohydrate binding-proteins |
| 04/14/1994 | WO1994007511A1 Antibodies detecting stromelysin cleavage products |
| 04/14/1994 | WO1994007474A1 Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids |
| 04/14/1994 | WO1994007469A1 An immunobooster for delayed release of immunogen |
| 04/14/1994 | WO1994007366A1 Pp14-based therapy |
| 04/14/1994 | CA2282888A1 Anti-inflammatory, tolerogenic and immunoinhibiting properties of carbohydrate binding peptides |
| 04/14/1994 | CA2211563A1 Anti-inflammatory tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides |
| 04/14/1994 | CA2146321A1 High potency vaccines |
| 04/14/1994 | CA2145769A1 Trophic factor having ion channel-inducing activity in neuronal cells |
| 04/14/1994 | CA2145762A1 Pp14-based therapy |
| 04/14/1994 | CA2145760A1 Method of enhancing cell mediated immune responses |
| 04/14/1994 | CA2145757A1 Human neutralizing monoclonal antibodies to human immunodeficiency virus |
| 04/14/1994 | CA2145391A1 Vaccines and antigenic conjugates |
| 04/14/1994 | CA2144850A1 Anti-inflammatory, tolerogenic and immunostimulatory properties of carbohydrate binding-proteins |
| 04/14/1994 | CA2144843A1 Antibodies detecting stromelysin cleavage products |
| 04/13/1994 | EP0592230A1 Human monoclonal anti-peptide anti-body and DNA encoding thereof |
| 04/13/1994 | EP0592220A2 Pharmaceutical composition or feedstuff containing a plant substance |
| 04/13/1994 | EP0592127A1 Immunoassay for isothiazolones |
| 04/13/1994 | EP0592106A1 Resurfacing of rodent antibodies |
| 04/13/1994 | EP0592026A1 Method for determining antigenic reactivity in urine |
| 04/13/1994 | EP0591914A2 Retrovirus of the HIV-group and its application |
| 04/13/1994 | EP0591697A2 Cloning and characterization of the growth hormone releasing hormone receptor |
| 04/13/1994 | EP0591452A1 Multiple emulsions and methods of preparation |
| 04/13/1994 | EP0591431A1 Hepatitis c virus (hcv) polypeptides |
| 04/13/1994 | EP0591385A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 04/13/1994 | EP0591384A1 Attenuated revertant serotype 1 marek's disease vaccine |
| 04/13/1994 | EP0591369A1 Capsid forming and cystein modified chimaeric ms2-coat protein |
| 04/13/1994 | EP0591320A1 Suppressor t-cell hybridoma |
| 04/13/1994 | EP0591281A1 Immunogen compounds having specifically an anti-cytokine effect, method of preparation, pharmaceutical compositions and kits containing them |
| 04/13/1994 | EP0591256A1 Methods for the synthesis of monofucosylated oligosaccharides terminating in di-n-acetyllactosaminyl structures |
| 04/13/1994 | EP0591254A1 Immunosuppressive and tolerogenic modified lewis?x and lewis?a compounds |
| 04/13/1994 | EP0549721B1 Multiple promoter baculovirus expression system and defective particle production |
| 04/12/1994 | US5302715 For binding to antigens, proteins, polypeptides or other labels for preparation of antibodies useful in immunoassays |
| 04/12/1994 | US5302703 For making antibodies or receptors to metabolism products of tetrahydrocannabinol for use in immunoassays |
| 04/12/1994 | US5302530 DNA coding for an antigen of Blastomyces dermatitidis |
| 04/12/1994 | US5302507 Antigenic peptide for detecting anti-hepatitis C virus antibodies and use thereof |
| 04/08/1994 | CA2107761A1 Human monoclonal anti-peptide antibody and dna encoding thereof |
| 04/07/1994 | DE4233646A1 New HIV-type immune deficiency virus ECACC V 92092318 |